Studies suggest the actuation of IL-6 in inflammation, mainly concerning hypertriglyceridemia associated with visceral obesity, increases insulin resistance and accumulation of hepatic fat, characteristic of non-alcoholic fatty liver disease (NAFLD) or hepatic steatosis [10,11]. The gene discussed is IL6; the disease is Hepatic steatosis.